$50 M for drug comparisons could produce valuable results.
Carroll
John
J
D000368:Aged; D004341:Drug Evaluation / Q000191:economics* / Q000379:methods; D004345:Drug Industry / Q000191:economics*; D018166:Health Care Reform / Q000331:legislation & jurisprudence*; D006801:Humans; D006278:Medicare / Q000331:legislation & jurisprudence*; D010606:Pharmacy and Therapeutics Committee; D012109:Research Support as Topic / Q000331:legislation & jurisprudence; D014481:United States